Abstract
Objective To describe the experience with COVID-19 patients hospitalized at University of New Mexico (UNM)
Methods First 50 adults admitted at the UNM between 1/19 to 4/24 2020 were included in this retrospective study
Results median age was 55 (20-85), 54% Female. Obesity (51%), diabetes (36%) and hypertension (34%) were most common comorbidities. Mean symptoms duration before admission 7days. Most common symptoms, subjective fevers (95.2%), cough (93%) and shortness of breath (87%). At triage 80% patients required oxygen, 20% required intubation. Differential 46% had elevated neutrophil counts and 48% had low lymphocytes counts. Median D dimer, Ferritin, CRP, LDH all elevated at presentation. 10% of patients had a negative chest x ray. 19.3% patients have coinfection with another respiratory pathogen. 68% patient required ICU level. 34% were directly admitted to ICU and 82.4% required invasive mechanical ventilation. Patients spent a median of 2 days on the floor prior to ICU transfer, median length of stay in the ICU-7 days. Patients with diabetes, and higher lactate dehydrogenase on admission were more likely to require ICU level of care. Of 34 patients in the ICU 13 died - overall mortality of 30.2%, Majority has AKI and required CRRT or HD. The median length of stay 7(Range 1-31days). 55% discharged home, 11% to rehabilitation facilities. 53.3% required oxygen on discharge.
Conclusion This study provides early experience in treating patient admitted to Academic Hospital in state of New Mexico.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This is a non funded study
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Alternative proof reader Devika Kapuria, MD: devika.kapuria{at}gmail.com
rahul547843{at}gmail.com, shubhra046762{at}gmail.com, drabubakersheikh{at}gmail.com, jmata{at}salud.unm.edu, devika.kapuria{at}gmail.com
Site of study: This study was performed at University of New Mexico Health Science Center.
Funding: This study is not funded
Conflict of Interest: None of the author reports conflict of interest
Study approval: Study approval was obtained from the University of New Mexico Health Science Center Institutional Review Board and waiver of consent was given
Data Availability
all data was extracted from electronic medical record and stored in red cap in de identified form
